IL111338A0 - Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation - Google Patents

Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation

Info

Publication number
IL111338A0
IL111338A0 IL11133894A IL11133894A IL111338A0 IL 111338 A0 IL111338 A0 IL 111338A0 IL 11133894 A IL11133894 A IL 11133894A IL 11133894 A IL11133894 A IL 11133894A IL 111338 A0 IL111338 A0 IL 111338A0
Authority
IL
Israel
Prior art keywords
pharmaceutical
preparation
treatment
viral infections
veterinary compositions
Prior art date
Application number
IL11133894A
Other languages
English (en)
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of IL111338A0 publication Critical patent/IL111338A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11133894A 1993-10-19 1994-10-19 Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation IL111338A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents

Publications (1)

Publication Number Publication Date
IL111338A0 true IL111338A0 (en) 1994-12-29

Family

ID=10743784

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11133894A IL111338A0 (en) 1993-10-19 1994-10-19 Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation

Country Status (26)

Country Link
EP (1) EP0739208A1 (es)
JP (1) JPH09505804A (es)
CN (1) CN1140992A (es)
AP (1) AP620A (es)
AU (1) AU7943794A (es)
BG (1) BG100599A (es)
BR (1) BR9407862A (es)
CA (2) CA2123825A1 (es)
CO (1) CO4520283A1 (es)
CZ (1) CZ113796A3 (es)
EE (1) EE9600057A (es)
GB (2) GB9321558D0 (es)
HR (1) HRP940688A2 (es)
HU (1) HUT76322A (es)
IL (1) IL111338A0 (es)
JO (1) JO1866B1 (es)
MA (1) MA23356A1 (es)
MD (1) MD960168A (es)
NO (1) NO961547L (es)
OA (1) OA10579A (es)
PE (1) PE5596A1 (es)
PL (1) PL314008A1 (es)
SK (1) SK50696A3 (es)
UY (1) UY23844A1 (es)
WO (1) WO1995011028A1 (es)
ZA (1) ZA948191B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (ja) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd インターフェロン用作用効果増強剤及び該増強剤とインターフェロンとを含有する抗ウイルス活性増強組成物
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
AU2003299486A1 (en) * 2002-05-10 2004-06-03 The Ohio State University Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (it) 2002-07-16 2004-01-16 Dayco Europe Srl Gruppo integrato puleggia-smorzatore torsionale
CN100413866C (zh) * 2002-08-02 2008-08-27 中国人民解放军军事医学科学院放射医学研究所 核黄素衍生物及其制备方法与应用
EP2545788A1 (de) * 2011-07-13 2013-01-16 Martin Hulliger Diätisches Mehrkomponentensystem
JP2018131410A (ja) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 カスパーゼ−３阻害剤とその用途
CN111565715A (zh) * 2017-10-24 2020-08-21 卢内拉生物技术有限公司 Mitoflavoscin：含靶向黄素的酶通过抑制线粒体呼吸作用消除癌症干细胞(CSCS)
CN114126603A (zh) * 2019-07-09 2022-03-01 帝斯曼知识产权资产管理有限公司 用核黄素或dha降低艾拉弗德的病毒活性

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (en) * 1989-08-14 1991-03-07 John Bennett Kizer Product and method for killing abnormal vertebrate cells
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (fr) * 1991-04-02 1995-03-10 Jean Berque Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (en) * 1991-11-25 1993-06-10 University Of Michigan Therapeutic composition and method for preventing reperfusion injury
JP3073309B2 (ja) * 1992-03-27 2000-08-07 雪印乳業株式会社 シアル酸結合５−デアザフラビン系化合物

Also Published As

Publication number Publication date
GB9321558D0 (en) 1993-12-08
GB9421099D0 (en) 1994-12-07
CA2174552A1 (en) 1995-04-27
BR9407862A (pt) 1997-05-20
OA10579A (en) 2002-06-19
HUT76322A (en) 1997-08-28
WO1995011028A1 (en) 1995-04-27
CO4520283A1 (es) 1997-10-15
PL314008A1 (en) 1996-08-05
CA2123825A1 (en) 1995-04-20
NO961547D0 (no) 1996-04-18
JO1866B1 (en) 1995-12-27
PE5596A1 (es) 1996-04-18
HRP940688A2 (en) 1997-04-30
AU7943794A (en) 1995-05-08
NO961547L (no) 1996-06-19
SK50696A3 (en) 1997-01-08
BG100599A (en) 1997-02-28
CZ113796A3 (en) 1996-11-13
MA23356A1 (fr) 1995-07-01
ZA948191B (en) 1995-06-08
HU9601006D0 (en) 1996-06-28
JPH09505804A (ja) 1997-06-10
EP0739208A1 (en) 1996-10-30
UY23844A1 (es) 1995-03-28
AP620A (en) 1997-10-14
GB2283913A (en) 1995-05-24
CN1140992A (zh) 1997-01-22
EE9600057A (et) 1996-10-15
AP9400695A0 (en) 1995-01-31
MD960168A (ro) 1998-04-30

Similar Documents

Publication Publication Date Title
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
CZ56595A3 (en) Substituted thiazolidinedione derivatives, process of their preparation, pharmaceutical preparation in which they are comprised and their use
CS257491A3 (en) 3-amidopyrazole derivatives, process of their preparation and pharmaceutical compositions comprising them
CA2293470A1 (en) Benzimidazole derivatives
MY107843A (en) Anti-viral compounds.
NZ238545A (en) Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof
AU4205789A (en) Method and composition for the treatment and prevention of viral infections
AU1937395A (en) Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
ZA936964B (en) Pharmaceutical compositions containing derivatives of nomegestrol and their process of manufacture
NZ228222A (en) 2(substituted-1-tetrahydropyridyl or substituted piperazinyl) propyl: isoindolinone derivatives; preparatory processes and pharmaceutical compositions
IL111338A0 (en) Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation
NZ225642A (en) Aralkylaminoalkoxyphenyl derivatives and pharmaceutical and veterinary compositions
AP9300581A0 (en) Benzofuran derivatives processes for their preparation and pharmaceutical compositions containing them and their medical use
IL105406A0 (en) Derivatives of adipogenesis inhibitory factor,processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
IL116925A (en) Combinations of compounds useful for treating HIV infections and pharmaceutical compositions comprising these combinations
IL106549A0 (en) Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
IL102116A (en) Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
FI965114A0 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
AU4787793A (en) Extract and pharmaceutical composition for treatment of calcium oxalate stone disease and viral infections
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
IL111138A0 (en) Pharmaceutical compositons comprising penciclovir and/or its derivatives for the treatment (including prophylaxis) of phn
HUP9802450A3 (en) Use of prostane derivatives and the combination thereof for preparing pharmaceutical compositions for use in treatment of bacterial infections